Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank93
3Y CAGR+16.2%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

3Y CAGR
+16.2%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM16.33%+21.5%
202413.44%-3.0%
202313.85%+33.2%
202210.40%+1941.4%
20210.51%+103.8%
2020-13.51%+51.4%
2019-27.77%+26.4%
2018-37.73%+96.4%
2017-1055.60%-
20160.00%-